Skip to main content
. 2015 Sep 10;5:14000. doi: 10.1038/srep14000

Figure 2.

Figure 2

(A) The Kaplan–Meier curve representing the association between the GSTO1 rs4925 genotypes and recurrence-free survival of patients treated with epirubicin. (B) The Kaplan–Meier curve representing the association between the GSTO1 rs4925 AA+AC vs. CC genotype and recurrence-free survival of patients treated with epirubicin.